# OnCo record paper-gounder-lancet-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-gounder-lancet-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-gounder-lancet-oncol" ;
  schema:name "Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study"@en ;
  schema:description "Paper cited by one cancer page and one trial page, indexed on Europe PMC as PubMed record 33035459 and published in The Lancet Oncology; the citing pages link this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-gounder-lancet-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(20)30451-4>, <https://pubmed.ncbi.nlm.nih.gov/33035459/>, <https://europepmc.org/article/MED/33035459> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(20)30451-4> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Gounder M, Schöffski P, Jones RL, et al." ;
  onco:related <https://onco.cc/cancers/epithelioid-sarcoma/> ;
  onco:trials <https://onco.cc/trials/tazemetostat-doxorubicin-es/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .